SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-20-023620
Filing Date
2020-11-12
Accepted
2020-11-12 16:10:59
Documents
91
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q nby20200930_10q.htm 10-Q 1756298
2 EXHIBIT 31.1 ex_210879.htm EX-31.1 9756
3 EXHIBIT 31.2 ex_210880.htm EX-31.2 9634
4 EXHIBIT 32.1 ex_210881.htm EX-32.1 4901
5 EXHIBIT 32.2 ex_210882.htm EX-32.2 5136
  Complete submission text file 0001437749-20-023620.txt   10487042

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT nby-20200930.xml EX-101.INS 2485470
7 XBRL TAXONOMY EXTENSION SCHEMA nby-20200930.xsd EX-101.SCH 110648
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nby-20200930_cal.xml EX-101.CAL 59928
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nby-20200930_def.xml EX-101.DEF 663036
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE nby-20200930_lab.xml EX-101.LAB 573669
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nby-20200930_pre.xml EX-101.PRE 703043
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33678 | Film No.: 201306761
SIC: 2834 Pharmaceutical Preparations